Reliability of White Matter Microstructural Changes in HIV Infection: Meta-Analysis and Confirmation.
Reliability of White Matter Microstructural Changes in HIV Infection: Meta-Analysis and Confirmation.
复制标题
DOI:
10.3174/ajnr.a5229
复制
发表时间:
2017-08
期刊:
影响因子:
--
通讯作者:
Zeffiro TA
中科院分区:
文献类型:
--
作者:
O'Connor EE;Jaillard A;Renard F;Zeffiro TA
Diffusion tensor imaging (DTI) has been widely used to measure HIV effects on white matter (WM) microarchitecture. While many have reported reduced fractional anisotropy (FA) and increased mean diffusivity (MD) in HIV, quantitative inconsistencies across studies are large. To evaluate the consistency across studies of HIV effects on DTI measures and then examine DTI reliability in a longitudinal seropositive cohort. The meta-analysis included 16 cross-sectional studies reporting FA and 12 studies reporting MD in the corpus callosum. Random effects meta-analysis was used to estimate study standardized mean differences (smd) and heterogeneity. DTI longitudinal reliability was estimated in seropositives studied before, and three and six months after, beginning treatment. Meta-analysis revealed lower FA (smd −0.43; p<0.0001) and higher MD (smd 0.44; p<0.003) in seropositives. Nevertheless, between study heterogeneity accounted for 58% and 66% of the observed variance (p<0.01). In contrast, the longitudinal cohort FA was higher and MD lower in seropositives (both p<.0001) and FA and MD measures were highly stable over six months, with intra-class correlation coefficients all >0.96. Many studies pooled participants with varying treatments, ages and disease durations. HIV effects on WM microstructure exhibited substantial variations that could result from acquisition, processing or cohort selection differences. When acquisition parameters and processing were carefully controlled, the resulting DTI measures did not show high temporal variation. HIV effects on WM microstructure may be age dependent. The high longitudinal reliability of DTI WM microstructure measures make them promising disease activity markers.